Fabian Falk started his scientific career with a Bachelor of Science of Applied Biology, followed up by a Master of Biology at the Karlsruher Institute of Technology (KIT). During his master studies, he specialized in molecular biology, technical biology, biotechnology and microbiology. Finishing his Master thesis in October of 2017, he started with his PhD in the group of Prof. Dr. Breitling at the institute of Microstructure Technology (IMT) which is in the last steps of completion. During this time, he was and still is a member of the BioInterfaces International Graduate School (BIF-IGS) and also worked as a guest scientist at the German Center of Cancer Research (DKFZ) in the group of Prof. Dr. Jörg Hoheisel and at the university hospital of Heidelberg (UK-HD) in the group of Dr. Nurjadi during his thesis work. While finishing his thesis he is involved in a new government funded project in the context of medical implantlogy.
- Bacterial Cell viability
- Antibiotic research
- Antibody Diagnostics
- Antibacterial nanostructures
- Safety regulations for biolological and genetic engineered matter.
- Histological-, bacterial- and Immunostaining
- Regular and laser-assisted light microscopy
- Hydrophobization of glass surfaces
- Laboratory Management
- Toxicity assays
Falk, F.; Zhou, Z.; Klinkusch A.; Weber L.; Breitling F. 2020. Patientenantikörper als Informationsquelle. Biospektrum, 26(5):556-558. DOI:10.1007/s12268-020-1440-0
Mamleyev, E. R.; Falk, F.; Weidler, P. G.; Heissler, S.; Wadhwa, S.; Nassar, O.; Shyam Kumar, C. N.; Kübel, C.; Wöll, C.; Islam, M.; Mager, D.; Korvink, J. G. 2020. 2020. ACS applied materials & interfaces, 12 (47), 53193–53205. DOI: 10.1021/acsami.0c13058